About CIMSEPP

A center and internationally recognized research, educational, and training body for materials science and engineering based design and manufacturing of particulate and composites

The team includes faculty from New Jersey Institute of Technology (NJIT, Lead Site, led by Prof. Raj Dave) and University of Minnesota (UMN, Partner Site, led by Prof. Calvin Sun), with significant large-center, academic and industrial experience.

Currently in the planning phase, if funded by NSF, the Phase I IUCRC will be for 5 years with NSF funding for administrative and operation costs. CIMSEPP research is to be supported in entirety by industry memberships, expected to be about $500K/year. Nearly 100 % of these funds are used to support direct research costs for pre-competitive research, results of which are shared by all members. All research projects are fully vetted by the Industry Advisory Board and are selected based on the IAB voting; Full members ($50K/year) get 1 vote, Associate members ($25K/year) get 0.5 vote. Industry members may also support post-competitive bilateral projects with any site(s) under preferred terms.

Advance and promote fundamental understanding of the material properties and interactions between drugs and additives at molecular and particulate level as affected by manufacturing processes on product quality, performance, and stability. Mission is:

• Advancing the fundamental understanding of structure-function-performance of drug products and process engineering, which pave the way for enhancing drug bioavailability and product stability through effective crystal and particle engineering;   
• Promoting translational research leading to knowledge generation and intellectual property; 
• Cultivating a holistic environment for open-minded industrial/academic interactions for targeted industrially relevant research; and
• Developing a diverse, well-trained workforce vital to maintaining US leadership in the field of integrated material science and engineering for pharmaceutical products.

• Pre-competitive scientific research portfolio valued at ~ $1.2M, representing significant 1:30 or higher leveraging of individual membership funds
• Direct access to Center faculty with vast experience of 100+ man-years research, 500+ high-quality journal papers, dozens of granted patents
• Members help determine the main research focus of the Center, and members select pre-competitive research projects
• Members have advance access to all research papers and reports, including work in progress and Non-Exclusive Royalty Free (NERF) license to use of all IP generated during their paid membership
• Semi-annual Industrial Advisory Board (IAB) meeting, members only seminars at no-cost
• Direct access to graduate students, postdocs and faculty through project mentorship program; opportunities for early, direct recruitment of highly trained students
• Join a forum that synergizes interactions between academics-industry to advance drug product design, manufacturing, regulatory aspects of current & emerging technologies